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Abstract
Background: COVID-19 was discovered in February in China. Due to the high prevalence of the disease, early
detection and rapid isolation of patients are the vital points for controlling the outbreak. The purpose of this study
was to determine the correct location of chest CT scan in the diagnosis of COVID-19.
Main text: The current study is a systematic review and meta-analysis. 2959 papers were found in all national and
international databases. The study has been reported based on the PRISMA checklist. All analyses were done by
CMA Ver. 2 software. The statistical analysis results show that the GGO observation level in the available shape was
46% in CT scan results, and the consolidation observation level in the general form was 33% in CT scan results.
Pleural effusion was 7%, and linear opacity observation level was 24% in CT scan results in the general form. The CT
scan test sensitivity level was gained 94.7%, and PCR test sensitivity level was achieved as 94.8%. This level was 89%
in the early stage.
Conclusion: The chest CT has about 24% higher diagnostic sensitivity than the PCR test, in the early stage. GGO
revealed a declining process and also indicates that GGO is an early symptom of the disease in CT scan. Linear
opacity is the reason behind the initial dyspnea in coronavirus suffering patients referring to the medical centers.
The extra-pulmonary lesions increase in the last stage of the disease that makes the patient’s worse.
Keywords: Chest CT, Coronavirus, RT-PCR, SARS-CoV-2
Background
The large family of coronaviruses was first discovered in
1960. Currently, seven species of this family are capable
of human-to-human transmission, three of which are
lethal. Between 2002 and 2003, the SARS-CoV global
epidemic (SARS-CoV) caused 8422 cases and killed 916
people [1]. Another strain, MERS-CoV, was first discov-
ered in Saudi Arabia in September 2012 and eventually
killed 858 people in the Middle East [2]. In December
2019, there were reports of a specific type of pneumonia
in Wuhan, China. The first patients probably worked or
attended one of the seafood markets in the city [3]. Since
then, cases have been overgrowing, and the disease has
spread to China and beyond. On February 11, 2020, the
World Health Organization (WHO) announced that the
official name was COVID-19 [4]. The disease primarily
causes respiratory tract infection and is transmitted
through respiratory droplets and contact. The incubation
period is between 1 and 14 days, and the main symp-
toms are fever, dry cough, and fatigue; besides, nonspe-
cific symptoms include shortness of breath, headache,
and muscle pain [5]. Due to the high prevalence of the
disease, early detection and rapid isolation of patients
are the vital points for controlling the outbreak. Al-
though RNA virus detection is a standard method, it still
has its drawbacks and limitations. The first thing about
using lab kits is that it takes a day or more to determine
the test result. Also, this method can only determine the
presence or absence of the disease and not judge the rate
of its progression. Imaging modalities are not only useful
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in determining the exact location of lesions but can also
help assess the extent of changes. Another is about
individual people (especially medical personnel who are
directly exposed to the disease); these people require
regular tests and perhaps daily tests because of frequent
contact. This is not possible because there is a lack of
kits in the world. The next reason is the diagnostic
quality of these kits. RT-PCR tests only use samples of
the upper chest cavity, although in most cases, the lower
chest abnormalities occur [6]. It should be noted that in
addition to the above reasons, numerous studies have
shown that RT-PCR kits are not highly sensitive, and in
some cases give false-negative results [7–11]. Early
radiological diagnosis can accelerate the planning for
conservative care. Computed tomography reports of the
first case of COVID-19 (a 47 years old patient) showed
that the disease manifestation usually occurs in high-
density, scattered shadows, mainly in the border regions
of the lung. Radiology and especially computed tomog-
raphy (CT) plays an essential role in the early detection,
and control of this disorder. Therefore, the purpose of
this study was to determine the correct location of
imaging modalities in the diagnosis of COVID-19.
Main text
Methods
The current study is a systematic review and meta-analysis
about COVID-19 diagnosis in chest CT: master key for ra-
diologists. The study was designed and implemented in
2020. This study has been reported based on the PRISMA
(Preferred Reporting Items for Systematic Reviews and
Meta-Analysis) checklist.
Search strategy
On March 17, 2020, the present study conducting
researchers got to search six international databases,
including MEDLINE/PubMed, ProQuest, Scopus, ISI,
Embase, Cochrane library, and Google Scholar as the
Gray Literature.
The selected keywords for the international databases
were coronavirus, coronavirus, 2019 nCov, COVID-19,
COVID 19, 2019-nCov, novel coronavirus, novel corona-
virus 2019, nCov, severe acute respiratory syndrome
coronavirus, Wuhan coronavirus, Wuhan seafood market
pneumonia virus, and SARS-nCov2.
The collected data were entered into EndNote version
X7 software, and the repeated papers were automatically
removed. It is worth noting that the two researchers
examined the documents separately.
Inclusion and exclusion criteria of related studies
All studies conducted until March 17, 2020, discovered
with the keywords in six databases, were included in the
study. Of course, the studies whose full version was not
at hand, the non-English ones, and the ones not dealing
with the current topic were crossed out.
Quality assessment
To analyze, and control the papers’ quality, the JBI check-
list developed by Joanna Briggs Institute was applied, and
it is used to evaluate various types of studies qualitatively.
In this research, three types of lists (cross-sectional, case
series, and cohort) were picked base on the inclusion
study type. Each list contains different questions that are
generally based on the quality of each study, as including
it or not, in the final analysis, is decided.
Screening studies
The initial search of the studies was done by two
individuals (S.H, and HA.N). The screening of the studies,
extracting the results, and also evaluating the papers’ qual-
ity was performed by two persons (Z.D and P.F) separately.
In case of a lack of consensus, the team supervisor (O.A)
announced the final comment about that paper.
Studies’ related bias risk
Sub-group analysis and Egger tests have been employed
to analyze the probability of bias in included studies.
Statistical analysis
The heterogeneity among the studies has been checked
by the Cochran test (significance level < 0.1), and its
combination using I2 statistics (significance level > 50%).
In the heterogeneity existence, the random-effects model
was applied by the variance inversion method, and in
the case of no heterogeneity, the fixed-effects model was
employed.
For analyzing the data, there were seven states as
GGO, consolidation, GGO, and consolidation; CP
pattern; lymphadenopathy; pleural effusion; and linear
opacity having the highest report in the studies were
chosen. Then, the probability of observing the onset of
symptoms, each of the states was analyzed based on the
disease’s stage (early, progress, and advance).
To measure the two tests’ sensitivity, two tests as CT
scan, and PRC were first separately employed based on
the disease stage. After that, the comparison between
the two trials was analyzed based on the calculated OR
(odds ratio) index.
The method used in the present research, known as
the calculated odds ratio (OR) index, was applied so that
the readers better figure out the paper. Comprehensive
Meta-Analysis (CMA) software owns the potential to
combine various indices and to integrate the sample size,
and the index difference is compared. According to the
conclusion, the OR index can well illustrate the gap
existing between the two tests. All analyses were done
by CMA Ver. 2 software.
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Results
Studies search description
Two thousand nine hundred fifty-nine papers were
found in all national and international databases that,
after deleting the repeated ones, 1482 articles got into
the analysis stage in terms of the title and abstract. After
addressing the papers’ titles and abstracts, 68 ones got
into the next step, where the full paper’s text was sur-
veyed, and 21 reports reached the final step. It is worth
stating that the included papers’ references were investi-
gated to add the relevant articles. In the studies’ screen-
ing stages, the reviews were excluded from analysis due
to various reasons encompassing irrelevant topic, irrele-
vant study population, and repeated results. The in-
cluded studies’ flow-chart is depicted in Fig. 1.
Included study description
The studies’ demographics are listed in Table 1. Out of
21 included studies, 17 cases were of China, two studies
in Italy, and two studies in South Korea.
Results of quality assessment
The results obtained from analyzing the studies’ qualita-
tive control based on the included reviews indicate that
all reviews possess desirable quality. The total results
of the studies’ qualitative assessment are covered in
supplementary file 1.
Heterogeneity-related results
Heterogeneity investigation-derived results of all ana-
lyses have been shown that in Table 2.
Results of meta-analysis
GGO
As the results suggest, the GGO observation level in the
general form was 46% (95% confidence intervals [CI];
38–54) in CT scan results. This level was 69% (95% CI;
56–79) in the early stage, 65% (95% CI; 22–92) in the
progress stage, and 32% (95% CI; 23–41) in the advance
stage. The GGO observation findings related to total
results in the patients’ CT scan are seen in Fig. 2.
Fig. 1 Flowchart of the included eligible studies in a systematic review
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Consolidation
The statistical analysis results show that the consolidation
observation level in the general form was 33% (95% CI;
25–43) in CT scan results. This level was 34% (95% CI;
24–46) in the early stage, 35% (95% CI; 25–43) in the pro-
gress stage, and 27% (95% CI; 12–48) in the advance stage.
The total results of the consolidation observation findings
in the patients’ CT scan are illustrated in Fig. 3.
GGO and consolidation
According to the results, GGO, and consolidation obser-
vation level in the general form was 61% (95% CI; 57–66)
in CT scan results. This level was 62% (95% CI; 57–66) in
the early stage and 9% (95% CI; 0–59) in the progress
stage. The total results of GGO and consolidation
observation findings in the patients’ CT scan are
depicted in Fig. 4.
Crazy paving pattern (CP pattern)
Based on the results, the CP pattern observation level
in the general form was 23% (95% CI; 16–32) in CT
scan results. This level was 21% (95% CI; 7–47) in
the early stage and 23% (95% CI; 16–33) in the
Table 2 Results of heterogeneity among included studies
Variable Category # of studies Q-value Df (Q) I-squared P-value Selected model
GGO Advance stage 2 0.291 1 0.0 0.590 Fixed
Early stage 15 231.07 14 93.94 < 0.001 Random
Progress stage 4 144.53 3 97.92 < 0.001 Random
Overall 21 394.99 20 94.93 < 0.001 Random
Consolidation Advance stage 1 0.0 0 0.0 0.999 Fixed
Early stage 12 151.16 11 92.72 < 0.001 Random
Progress stage 4 81.91 3 96.33 < 0.001 Random
Overall 17 238.65 16 93.29 < 0.001 Random
GGO & Consolidation Early stage 5 2.65 4 0.0 0.618 Fixed
Progress stage 2 13.07 1 92.35 < 0.001 Random
Overall 7 81.49 6 92.63 < 0.001 Random
CP Pattern Early stage 5 2.65 4 0.0 0.618 Fixed
Progress stage 2 13.07 1 92.35 < 0.001 Random
Overall 7 81.49 6 92.63 < 0.001 Random
Lymphadenopathy Advance stage 2 1.45 1 31.21 0.228 Fixed
Early stage 6 18.56 5 73.06 0.002 Random
Progress stage 2 0.11 1 0.0 0.738 Fixed
Overall 10 31.51 9 71.44 < 0.001 Random
Pleural effusion Advance stage 1 0.0 0 0.0 0.999 Fixed
Early stage 7 14.76 6 59.34 0.022 Random
Progress stage 2 0.01 1 0.0 0.893 Fixed
Overall 10 17.98 9 50.95 0.035 Random
Linear Opacity Early stage 4 16.53 3 81.85 0.001 Random
Progress stage 3 0.04 2 0.0 0.978 Fixed
Overall 7 103.26 6 94.19 < 0.001 Random
Diagnosis test (CT scan) Advance stage 2 0.40 1 0.0 0.523 Fixed
Early stage 21 79.62 20 74.88 < 0.001 Random
Progress stage 6 8.97 5 44.29 0.110 Fixed
Overall 29 89.0 28 70.52 < 0.001 Random
Diagnosis test (PCR) Advance stage 1 0.0 0 0.0 0.999 Fixed
Early stage 6 34.73 5 85.60 < 0.001 Random
Progress stage 5 12.14 4 67.05 0.016 Random
Overall 12 177.27 11 93.79 < 0.001 Random
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progress stage. CP pattern-related total results in the
ST scan of patients are shown in Fig. 5.
Lymphadenopathy
The statistical analysis extracted results denoted that
lymphadenopathy observation level was 6% (95% CI; 4–
10) in CT scan results. This level was 4% (95% CI; 1–9)
in the early stage, 4% (95% CI; 2–8) in the progress
stage, and 15% (95% CI; 9–23) in the advance stage.
Lymphadenopathy observation-based total results in the
CT scan of patients are shown that in Fig. 6.
Pleural effusion
The statistical analysis results indicated that pleural effu-
sion in the general form was 7% (95% CI; 5–10) in CT
scan results. This level was 5% (95% CI; 3–9) in the early
stage, 6% (95% CI; 4–10) in the progress stage, and 12%
(95% CI; 6–21) in the advance stage. The total results of
pleural effusion observation in the patients’ CT scans are
depicted in Fig. 7.
Linear opacity
Based on the results, the linear opacity observation level
in the general form was 24% (95% CI; 20–29) in CT scan
Fig. 2 Results of GGO in CT scan of patients
Fig. 3 Results of GGO in CT scan of patients
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results. This level was 52% (95% CI; 38–65) in the early
stage and 20% (95% CI; 16–24) in the progress stage.
Linear opacity-related total results in the patients’ CT
scans are demonstrated in Fig. 8.
CT scan test sensitivity
As the statistical analysis results suggest, CT scan test
sensitivity level in the general form was gained 94.7%
(95% CI; 91.8–96.6). This level was 94.2% (95% CI; 90.7–
96.4) in the early stage, 90% (95% CI; 85.1–93.6) in the
progress stage, and 99% (95% CI; 92.3–99.8) in the ad-
vance stage. CT scan test sensitivity-related total results
are depicted in Fig. 9.
PCR test sensitivity
According to statistical analysis results, the PCR test
sensitivity level was achieved as 94.8% (95% CI;
90.4–97.2) in the general form. This level was 89%
(95% CI; 72.3–96.3) in the early stage, 95.8% (95%
CI; 90.8–98.1) in the progress stage, and 99.4% (95%
CI; 91–100) in the advance stage. PCR test sensitiv-
ity relevant total results are given in Fig. 10.
Comparing CT scan and PCR tests
As revealed by calculated OR index, generally speaking,
CT scan and PCR tests did not show statistically signifi-
cant (OR=1.001, 95% CI; 0.91–1.11, p= 0.851; I2= 94.97,
p < 0.001), while according to data analysis, CT scan test
showed approximately 24% higher sensitivity than PCR
in the early stage (comparison of CT and PCR tests sec-
tion, based on the data analyzed in Fig. 11), the finding
which was not statistically significant (OR=1.24, 95% CI;
0.76–2.03, p= 0.383; I2= 94.97, p < 0.001). The total re-
sults of a comparison between CT scan and PCR tests
are seen in Fig. 11.
Fig. 4 Results of GGO in CT scan of patients
Fig. 5 Results of GGO in CT scan of patients
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Publication bias
To investigate publication bias in the results, the Egger
test and funnel plot extracted results were applied. The
obtained results indicate no significant error spotted in
the works (p = 0.747). The funnel plot of publication
bias analysis is observed in Fig. 12.
Discussion
One of the goals the current research pursues is to com-
pare the diagnostic percent of chest CT and RT-PCR to
obtain the most effective method for diagnosing
COVID-19, and the findings exhibit that chest CT scan
was 24% more sensitive than RT-PCR in the early stages
of the disease diagnosis. Likewise, the study done by Tao
Ai showed that RT-PCR plays a fundamental role in iso-
lating and hospitalizing COVID-19 suffering patients.
Still, the factors like sampling operation, sampling
sources (sampling location in the respiratory tract or
lung), sampling time, and the diagnostic kit’s quality im-
pair it relative to chest CT in the early disease diagnostic
stages. On the one hand, chest CT determines pulmon-
ary engagement and progression of the disease and is
less affected by human error [6–11, 30–34].
The present study-derived findings suggest that GGO
outbreak level is around 69% in the early diagnostic
stages of COVID-19 in chest CT. Similarly, GGO was
seen in the majority of the studies on coronavirus suffer-
ing patients undergoing CT scan tests [17, 30–32, 35].
In some studies such as Li et al.’s research, only GGO
was analyzed in chest CT; this issue indicates the physi-
cians’ experimental perception of this symptom outbreak
in chest CT images [13, 24, 35, 36]. Generally speaking,
Fig. 6 Results of GGO in CT scan of patients
Fig. 7 Results of GGO in CT scan of patients
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the abovementioned findings suggest that probably
GGO is of coronavirus clinical sign in chest CT images,
and this itself approves the present research [37]. It is
worth mentioning that in some tasks, such as the one by
Li et al., only the GGO was analyzed in chest CT. This
issue indicates the physicians’ experimental perception
of this symptom outbreak in chest CT images [13, 24,
35, 36]. Generally speaking, the abovementioned findings
suggest that probably the GGO is of coronavirus suffer-
ing patients’ clinical symptoms in chest CT images, and
this itself approves the present research [37]. Besides, as
stated by the study of Xu et al., crazy paving pattern
is a particular state of the GGO. Thus, it has to
include a lower percentage of GGO; the issue shown
by this study [35].
The studies’ analysis-derived results revealed that con-
solidation symptom’s incidence in chest CT images is
generally 33% (a pulmonary consolidation is a region of
normally compressible lung tissue that has filled with li-
quid instead of air), and also consolidation results from
inflammatory exudation by alveoli filling, which means
the virus spreads through the respiratory epithelium and
Fig. 8 Results of GGO in CT scan of patients
Fig. 9 Results of GGO in CT scan of patients
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leads to alveoli damage and necrotic bronchitis. It has to
be stated that this finding has been investigated by Li
et al. [29, 38–40]. MIX state or the simultaneous pres-
ence of consolidation, and GGO in the early stage of
diagnosis has gained a high percentage (61%). This high
percentage has been confirmed in several other studies
[15, 21, 23, 41]. This study extracted results showing
that the linear opacity is generally 24% and 52% in the
early stage of diagnosis. The linear opacity indicates a
decrease of air to tissue ratio due to pathogens. This
is probably the reason behind the initial dyspnea in
coronavirus suffering patients referring to the medical
centers. The presence of the linear opacity in chest
CT images of the patients has been supported in the
study by Chung et al. [18]. As stated by the research
of Kunhua et al., the extra-pulmonary lesions such as
pleural effusion signal severe inflammation as less
than 10% in the present study generally and increas-
ing in the last stage of the disease due to the grave
condition of some of the patients [29].
Comparing the different stages of the disease diagnosis
in this study demonstrates that the clinical manifestations
Fig. 10 Results of GGO in CT scan of patients
Fig. 11 Results of GGO in CT scan of patients
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of the study did not change much (symptoms of corona-
virus on chest CT imaging). However, the GGO revealed
a declining process, and it is probably due to recovery over
time and also indicates that the GGO is an early symptom
of the disease [24, 42].
Conclusion
To sum up, the chest CT and PCR-induced results are
almost identical with no meaningful difference. Though,
in the early stage of the disease diagnosis, chest CT has
about 24% higher diagnostic accuracy than PCR test. In
the early stage of disease diagnosis as the most critical
one, the most prevalent COVID-19-induced symptoms
in chest CT are GGO and Mix (GGO and consolida-
tion). Analyzing all stages of the disease diagnosis
showed that the highest incidence in chest CT images
are related to GGO and Mix (GGO, and Consolidation),
and the least are of pleural effusion and lymphadenop-
athy. Moreover, in the current research, it has been
found that GGO is the early symptom of the disease and
declines over time. Also, the extrapulmonary lesions
such as pleural effusion signal severe inflammation in
the disease advance stage due to the grave condition of
some of the patients have increased.
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